LangAware Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$323K
- Investors
-
6
LangAware General Information
Description
Developer of diagnosis technology designed to be used for the early detection of various neurodegenerative diseases. The company's technology uses artificial intelligence and machine learning to predict neurodegenerative diseases by detecting and monitoring digital biomarkers based on language and speech, enabling physicians and patients to have an early cognitive assessment to prevent Alzheimer's and related dementias.
Contact Information
Website
www.langaware.comCorporate Office
- 1209 North Orange Street
- Wilmington, DE 19801
- United States
Corporate Office
- 1209 North Orange Street
- Wilmington, DE 19801
- United States
LangAware Timeline
LangAware Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 28-Mar-2025 | $323K | Completed | Generating Revenue | ||
| 5. Seed Round | 04-Oct-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Seed Round | 09-Dec-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2021 | $650K | Completed | Generating Revenue | ||
| 1. Seed Round | 22-Jul-2020 | $650K | $650K | Completed | Generating Revenue |
LangAware Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 2,869,925 | $0.000107 | $0.22 | $0.22 | 1x | $0.22 | 15.42% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
LangAware Patents
LangAware Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3809411-A1 | Multi-lingual system for early detection of alzheimer's disease | Active | 18-Oct-2019 | ||
| EP-3809411-B1 | Multi-lingual system for early detection of alzheimer's disease | Active | 18-Oct-2019 | ||
| US-20210118465-A1 | Multi-lingual system for early detection of alzheimer's disease | Active | 18-Oct-2019 | ||
| US-11114113-B2 | Multilingual system for early detection of neurodegenerative and psychiatric disorders | Active | 18-Oct-2019 | G10L25/66 |
LangAware Signals
LangAware Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cleverage Venture Capital | Venture Capital | Minority | ||
| Eleven Ventures | Venture Capital | Minority | ||
| Endeavor Greece | Accelerator/Incubator | |||
| P4 Precision | Accelerator/Incubator | |||
| Angel (individual) | Minority |
LangAware FAQs
-
When was LangAware founded?
LangAware was founded in 2019.
-
Where is LangAware headquartered?
LangAware is headquartered in Wilmington, DE.
-
What is the size of LangAware?
LangAware has 11 total employees.
-
What industry is LangAware in?
LangAware’s primary industry is Decision/Risk Analysis.
-
Is LangAware a private or public company?
LangAware is a Private company.
-
What is LangAware’s current revenue?
The current revenue for LangAware is .
-
How much funding has LangAware raised over time?
LangAware has raised $4.6M.
-
Who are LangAware’s investors?
Cleverage Venture Capital, Eleven Ventures, Endeavor Greece, P4 Precision, and are 5 of 6 investors who have invested in LangAware.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process